Circulogene is the leader in liquid biopsies. By applying proprietary cell-free DNA recovery and enrichment technology, Circulogene is the first and only company to use minimal-volumes of blood to monitor tumors and the first company to develop a next-generation sequencing method to provide full genomic load analysis. Circulogene is founded and operated by leaders and scientists from the diagnostics industry.
Mike Mullen, President and CEO
Mike Mullen has more than 25 years in executive and financial leadership positions. He was most recently the President and CEO of Atherotech Diagnostics. Prior to Atherotech, Mike held various financial positions with several companies including Ernst &Young. Mike holds both medical technology and accounting degrees and was the Southeast recipient of the Ernst & Young Entrepreneur of the Year award in 2014.
Dr. Chen-Hsiung Yeh, Chief Scientific Officer
Dr. Chen-Hsiung Yeh has over 20 years’ experience drug discovery and molecular diagnostics in the biotech, pharmaceutical and diagnostic industries. He has held leadership roles at Pfizer, Response Genetics, Quest Diagnostics, and most recently Atherotech Diagnostics. Chen is a pioneer in the liquid biopsy field and the inventor of Circulogene’s core technology.
Scott Rezek, Chief Operating Officer
Scott Rezek has managed global project teams, national sales forces, marketing and technology teams, and service organizations. His most recent position was Chief Commercial Officer at Atherotech Diagnostics. Prior to that, Scott was Director of Marketing/Global E-Business at Invitrogen. He holds master’s and bachelor’s degrees in marketing.
Dr. Kathryn Clary, Lab Director
Dr. Kathryn Clary has been a practicing pathologist for seven years and is certified by the American Board of Pathology in Anatomic and Clinical Pathology with a subspecialty in Cytopathology. She received her medical degree from the University of Alabama School of Medicine and completed residency and fellowship training at the University of Alabama at Birmingham Hospital. Dr. Clary is a Fellow of the American Society of Clinical Pathology and College of American Pathologists.
Dr. Ben Boedeker, Clinical Research Advisor
Dr. Ben Boedeker is both a Professor and the Director of the Center for Advanced Technology & Telemedicine at the University of Nebraska Medical Center. A retired USAFR Colonel, Dr. Boedeker earned his MD from John Burns School of Medicine, PhD in Pathology from Georgetown University, and DVM from Colorado State University. Dr. Boedeker holds numerous patents in novel sustained release drug delivery systems.
Dr. Glen Weiss, Chief Medical Officer
Dr. Glen Weiss was the recent Director of Clinical Research & Trials at the Cancer Treatment Centers of America. He has published over 275 peer-reviewed articles and has received research funding from institutions such as the American Cancer Society and the National Foundation for Cancer Research. He completed medical school at Sackler School of Medicine, internal medicine residency at SUNY-Downstate, and a hematology/oncology fellowship at University of Colorado, and earned a MBA at W.P. Carey School of Business. In 2016, he received the Healthcare Leadership Researcher of the Year award from AZ Business Magazine.